Un-spoken discrimination against older patients with blood cancer may be happening in hospitals because of “quiet rationing” of the expensive drugs such as tyrosine kinase inhibitors, acco
Joerg Hasford
Un-spoken discrimination against older patients with blood cancer may be happening in hospitals because of “quiet rationing” of the expensive drugs such as tyrosine kinase inhibitors, according to Professor Joerg Hasford from the Department of Epidemiology at the Ludwig-Maximillians University of Munich. He talked with ecancer radio about the evidence he has accumulated from a study — originally designed to look into discrimination against female patients — which he presented to the conference on blood cancer in the elderly held in Rome.
LISTEN
[audio:https://www.audiomedica.com/podcasting/ecancer/110411JoergHasfordPODCASTLoRes.mp3]